Delivery Order SPE2DB22D3004-SPE2DB25FRK06
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,604.63, is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,830.00 contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a period of performance through July 31, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and is a firm fixed price delivery order with a period of performance through July 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,830.00 contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a period of performance through June 30, 2025. The award is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, with a ceiling value of $11,830.00 and a period of performance through August 6, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The contract has a ceiling value of $11,830.00 and is a firm fixed price contract. It is not designated as a set-aside contract, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. The award has a firm fixed price of $11,827.51 and a performance period through April 3, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and serves as a prime vendor providing a wide range of pharmaceutical products and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a prescription medication, with a ceiling value of $11,830.00 and a completion date of July 3, 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a medical product, with a ceiling value of $11,830.00 and a performance period ending on July 15, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is the prime contractor and there...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML pharmaceutical products. The delivery order has a potential value of $23,655.02 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is part of a larger indefinite...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRK06Delivery Order
This is a firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the medication SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, with a ceiling value of $11,830.00 and a period of performance through July 31, 2025. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 7/10/25 |